The BCW Index climbed 1.59 percent for the trading week ended Tuesday. Only five of the components of the Index declined for the week, and none of them dropped more than 1.6 percent. Stratagene led gainers for the tracking period, closing up 6.7 percent.

In comparison, the Dow Jones Industrial Average gained .9 percent, while both the Nasdaq and Nasdaq Biotech Index rose 2.6 percent.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.